Not Yet Recruiting NA INTERVENTIONAL 4-arm NCT06666101

Effects of n3 LC PUFAs on Inflammatory, Immune and Senescence Features in Polyvascular Older Subjects (OMSAGE) (OMSAGE)

Immunomodulatory Effects of Polyunsaturated ω-3 Fatty Acids in Old Patients With Polyvascular Disease: a Double-blind, Randomized, Controlled, Factorial 2x2 Trial (OMEGA3 Study)

Sponsor: University of Mons

Conditions Polyvascular Disease

Interventions Long chain polyunsaturated Omega-3 Placebo

Updated 1 time since 2024 Last updated: Oct 28, 2024 Started: Nov 4, 2024 Primary completion: Nov 4, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06666101, this NA trial focuses on Polyvascular Disease and remains actively recruiting participants. Sponsored by University of Mons, it has been updated 1 time since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

1 version recorded

Not Yet Recruiting — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Mons
Université Catholique de Louvain
Université Libre de Bruxelles

Data source: Université Libre de Bruxelles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.